The neuroendocrine tumor is often located in the gastrointestinal wall at a level similar to that of GST, so we speculate that this approach is feasible for the treatment of GSTs with a diameter smaller than 1.0 cm. This evidence concerns the gene HPGDS and neuroendocrine neoplasm.